These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30058568)

  • 1. A prospective study of the epidemiological and clinical patterns of recurrent dermatophytosis at a tertiary care hospital in India.
    Pathania S; Rudramurthy SM; Narang T; Saikia UN; Dogra S
    Indian J Dermatol Venereol Leprol; 2018; 84(6):678-684. PubMed ID: 30058568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study.
    Tahiliani S; Saraswat A; Lahiri AK; Shah A; Hawelia D; Shah GK; Girdhar M; Rao PN; Raghav PA; Agarwal P; Kharkar RD; Gupta RP; Udare S; Hegde S; Haldar S
    Indian J Dermatol Venereol Leprol; 2021; 87(6):800-806. PubMed ID: 34160163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
    Singh S; Chandra U; Anchan VN; Verma P; Tilak R
    Br J Dermatol; 2020 Nov; 183(5):840-846. PubMed ID: 32538466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center.
    Mahajan S; Tilak R; Kaushal SK; Mishra RN; Pandey SS
    Indian J Dermatol Venereol Leprol; 2017; 83(4):436-440. PubMed ID: 28540871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates.
    Salehi Z; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1841-1846. PubMed ID: 29980898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicomycological Profile and Risk Factors for Dermatophytosis at a Teaching Tertiary Care Centre in North India: A Cross-sectional Study.
    Singla P; Garg S; Singh P; Sharma N; Mane P; Singh NK; Sharma S
    Infect Disord Drug Targets; 2023; 23(6):e280423216334. PubMed ID: 37132314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: Genomic insights and resistance profile.
    Singh A; Masih A; Monroy-Nieto J; Singh PK; Bowers J; Travis J; Khurana A; Engelthaler DM; Meis JF; Chowdhary A
    Fungal Genet Biol; 2019 Dec; 133():103266. PubMed ID: 31491507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological response and clinical profile in patients with recurrent dermatophytosis.
    Jha K; Shaw D; Karim A; Narang T; Saikia B; Rudramurthy SM; Saikia UN; Dogra S
    Mycoses; 2021 Nov; 64(11):1429-1441. PubMed ID: 34010462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
    Salehi Z; Fatahi N; Taran M; Izadi A; Badali H; Hashemi SJ; Rezaie S; Daie Ghazvini R; Ghaffari M; Aala F; Barac A; Khodavaisy S
    J Mycol Med; 2020 Jun; 30(2):100935. PubMed ID: 32139093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the in vitro susceptibility pattern of clinical isolates of Trichophyton mentagrophytes and Trichophyton rubrum in Santiago, Chile].
    Díaz Jarabrán MC; Díaz González P; Espinoza Rodríguez J; Carrillo Muñoz AJ
    Rev Iberoam Micol; 2015; 32(2):83-7. PubMed ID: 24794211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species Distribution and Antifungal Susceptibility Profile of Dermatophytes from a Tertiary Care Centre in North India.
    Kumar MB; Gulati N; Chander J; Singla N; Bhalla M; Nayyar C; Sharma S; Kaur M
    J Lab Physicians; 2022 Dec; 14(4):449-455. PubMed ID: 36531552
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of Recalcitrant Dermatophytosis in a Multicenter Study in Sri Lanka.
    Madarasingha NP; Eriyagama S; Jayasekera PI; de Silva Weliange S; Gunasekera S; Munasingha DM; Rajendran P; Ekanayaka SMB; Liyanange J; Thamilvannan N; Sumanasena B; Srisaravanabavanathan F; Wijenayake B
    Am J Trop Med Hyg; 2022 Jul; 107(1):117-121. PubMed ID: 35895368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Clinical-Mycological Study of Dermatophytosis in Western India with Focus on Antifungal Drug Resistance as a Factor in Recalcitrance.
    Shah SR; Vyas HR; Shah BJ; Jangid NC; Choudhary A; Gehlawat T; Mistry D; Joshi R
    Indian J Dermatol; 2023; 68(2):234. PubMed ID: 37275803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-Mycological Profile of Treatment-Naïve, Chronic, Recurrent and Steroid-Modified Dermatophytosis at a Tertiary Care Centre in Eastern India: An Institution-Based Cross-SectionalStudy.
    Saha I; Podder I; Chowdhury SN; Bhattacharya S
    Indian Dermatol Online J; 2021; 12(5):714-721. PubMed ID: 34667758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End of the road for terbinafine? Results of a pragmatic prospective cohort study of 500 patients.
    Singh S; Shukla P
    Indian J Dermatol Venereol Leprol; 2018; 84(5):554-557. PubMed ID: 29893296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication Practice of Patients with Dermatophytosis.
    Poudyal Y; Joshi SD
    JNMA J Nepal Med Assoc; 2016; 55(203):7-10. PubMed ID: 27935915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tinea universalis due to Trichophyton indotineae in an adult male.
    Thakur R; Kushwaha P; Kalsi AS
    Indian J Med Microbiol; 2023; 46():100476. PubMed ID: 37806168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cross-Sectional Clinicomycological Study on Dermatophytosis: A Report From a Single Tertiary Healthcare Center in Eastern India.
    Das D; Mondal H; Deb Roy A; Anand A; Maiti P; Ray A
    Cureus; 2022 Nov; 14(11):e31728. PubMed ID: 36569693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Clinico-mycological, Antifungal Drug Sensitivity and Therapeutic Study of Extensive Dermatophytosis in Coastal Andhra Pradesh.
    Vanapalli S; Turpati NR; Gopal KVT; Krishnam Raju PV; Devi BG
    Indian Dermatol Online J; 2022; 13(6):747-753. PubMed ID: 36386757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common dermatophytes and in vitro anti-fungal susceptibility testing in patients attending the Dermatological Clinic at the Hospital for Tropical Medicine, Bangkok.
    Muangkaew W; Wongsuk T; Luplertlop N
    New Microbiol; 2017 Jul; 40(3):175-179. PubMed ID: 28513812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.